Active Clinical Trials

Nivolumab in Patients With Recurrent Malignant Mesothelioma

By April 24, 2017 No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 33

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: N14MPN

Study First Received: July 6, 2015

Last Updated: February 27, 2017

Estimated Primary Completion Date: July 2017


Primary Outcome Measures:

DCR|PFS|OS|TTP|ORR|Safety and tolerability (The incidence of (serious) adverse events)

Sponsors and Collaborators:

The Netherlands Cancer Institute|Bristol-Myers Squibb

Website Link:

Leave a Reply

Call Now ButtonCall Now